Loading…

Introduction to the Food and Drug Administration (FDA) Regulatory Process

FDA oversight of medical devices, including in vitro diagnostic devices (IVDs or laboratory tests), in the United States was a direct result of the passage of the Medical Device Amendments of 1976. This law introduced a series of general controls for medical devices including registration and listin...

Full description

Saved in:
Bibliographic Details
Published in:Journal of proteome research 2005-07, Vol.4 (4), p.1110-1113
Main Authors: Hackett, Joseph L, Gutman, Steven I
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:FDA oversight of medical devices, including in vitro diagnostic devices (IVDs or laboratory tests), in the United States was a direct result of the passage of the Medical Device Amendments of 1976. This law introduced a series of general controls for medical devices including registration and listing, requirements for production using good manufacturing practices, and requirements for post-market reporting of device failures. This produced for the first time a menu of laboratory tests on the market, a system to ensure these were produced consistently over time, and a mechanism for FDA to identify problems with device use and to work with companies to ensure corrective action. This law also introduced the requirement for premarket review of new versions of old devices and of fundamentally new medical devices. Keywords: genomics • proteomics • FDA • in vitro diagnostic • biomarkers • pre-IDE
ISSN:1535-3893
1535-3907
DOI:10.1021/pr050059a